FinTechFunding

Medlab Clinical: Recieves Australian patent for NanoCelle

  • Biotech company Medlab Clinical (MDC) has been granted an Australian patent for its NanoCelle delivery platform
  • Essentially, NanoCelle delivers drug formulations via an oral spray
  • So far, product testing results have indicated the spray can lead to better absorption of the drugs, helping the formulation avoid ingested routes
  • It can also potentially lower drug dosages and reduce the side effects of some formulations
  • Medlab has also filed patent applications in other jurisdictions, such as the U.S., Europe and New Zealand
  • On the market this afternoon, Medlab is up 3.03 per cent, trading for 17 cents per share
Previous article
Xantippe Resources: Receives preliminary results from Southern Cross drilling
Next article
Argonaut Resources: Raises $2.7M for copper exploration
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

NYSE Parent Invests $600M in Polymarket, Strengthening Market Position

This significant investment signals confidence in the future of predictive markets.Highlights: NYSE's parent company allocates $600M to Polymarket.Investment...
FinTech

Nexi Expands SEPA Direct Debit with Danish Banks, Enhancing Payments Integration

Nexi's collaboration with Danish banks aims to strengthen payment services across Europe.Highlights: Nexi partners with several Danish banks...
FinTech

Lloyds Confirms App Glitch Exposed Data of Almost Half a Million Customers

The significant data breach prompts concerns over customer privacy.Highlights: Lloyds Banking Group admits to a data breach affecting...
FinTech

Mastercard Restricts Sale of Nets Payments Unit Purchased for $3.2 Billion

Mastercard looks to divest its Nets payments segment as part of strategic realignment.Highlights: Mastercard is seeking to sell...